Carmichael Hill & Associates »

Avadel Pharmaceuticals shares owned by Carmichael Hill & Associates

Quarter-by-quarter ownership of Avadel Pharmaceuticals (AVDL) shares owned by Carmichael Hill & Associates from 13F filings

Historical chart of Carmichael Hill & Associates investment in Avadel Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Avadel Pharmaceuticals held by Carmichael Hill & Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Avadel Pharmaceuticals by Carmichael Hill & Associates

Quarter filed Position value Share count Share price at filing
2024-09-30 $275k 21k 13.12
2024-06-30 $295k 21k 14.06

More positions owned by Carmichael Hill & Associates

Apple Call Call Option (Principal) (AAPL)
Microsoft Corp Call Call Option (Principal) (MSFT)
Schwab Strategic Tr Us Brd Mkt Etf (SCHB)
Berkshire Hathaway Inc Del Call Call Option (Principal) (BRK.B)
Schwab Strategic Tr Us Lrg Cap Etf (SCHX)
Vanguard World Inf Tech Etf (VGT)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Spdr Ser Tr S&p Divid Etf (SDY)
Vanguard Index Fds Small Cp Etf (VB)
Alphabet Call Call Option (Principal) (GOOGL)
Schwab Strategic Tr Intl Eqty Etf (SCHF)
Vanguard Mun Bd Fds Tax Exempt Bd (VTEB)
Ishares Tr Core S&p500 Etf (IVV)
Vanguard Whitehall Fds High Div Yld (VYM)
Schwab Strategic Tr Us Mid-cap Etf (SCHM)

View all positions for Carmichael Hill & Associates

Top funds holding Avadel Pharmaceuticals

Henderson Group
Jeffrey L. Gendell
BlackRock
Polar Capital Holdings
Two Seas Capital
Braidwell
Vanguard Group
Citadel Advisors
Vivo Capital
Wealth Effects
Brandes Investment Partners
Goldman Sachs Group
Vestal Point Capital
State Street Corporation
Tri Locum Partners

View all funds holding Avadel Pharmaceuticals